Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort.

Shimohama S, Bun S, Shikimoto R, Tomioka H, Takayama T, Mimura Y, Sasaguri H, Sekiguchi K, Nishimoto Y, Iwabuchi Y, Tabuchi H, Nakahara J, Mimura M, Ito D

Open source

DOI: 10.1002/dad2.70492
Published: 2026 Jul-Sep
Container: Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70492,
  title = {Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort.},
  author = {Shimohama S and Bun S and Shikimoto R and Tomioka H and Takayama T and Mimura Y and Sasaguri H and Sekiguchi K and Nishimoto Y and Iwabuchi Y and Tabuchi H and Nakahara J and Mimura M and Ito D},
  year = {2026},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70492},
  url = {https://doi.org/10.1002/dad2.70492}
}

RIS

TY  - JOUR
TI  - Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort.
AU  - Shimohama S
AU  - Bun S
AU  - Shikimoto R
AU  - Tomioka H
AU  - Takayama T
AU  - Mimura Y
AU  - Sasaguri H
AU  - Sekiguchi K
AU  - Nishimoto Y
AU  - Iwabuchi Y
AU  - Tabuchi H
AU  - Nakahara J
AU  - Mimura M
AU  - Ito D
PY  - 2026
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70492
UR  - https://doi.org/10.1002/dad2.70492
ER  -

APA

S, S., S, B., R, S., H, T., T, T., Y, M., H, S., K, S., Y, N., Y, I., H, T., J, N., M, M., & D, I. (2026). Real-world implementation of lecanemab in Alzheimer's disease: A Japanese cohort.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70492

Source records

pubmed · retrieved 2026-09-27T09:46:16.434Z